Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
Journal of Cellular & Molecular Anesthesia,
Vol. 6 No. 4 (2021),
21 January 2022
,
Page 339-342
https://doi.org/10.22037/jcma.v6i4.35302
Abstract
Severe COVID-19 disease is currently being managed with glucocorticoids. As a result, there are increasing reports of COVID-19 associated mucormycosis. (CAM) Patients with diabetes mellitus, organ transplant recipients, and in immune-compromised patients either due to cancer chemotherapy or with HIV and AIDS are at high risk of developing CAM. Pharmacotherapy with antifungal agents like Amphotericin B and surgery are the main treatment options. In this narrative review, we will discuss the challenges and anesthetic concern while managing CAM.
- COVID-19 associated mucormycosis
- Airway
- Anesthetic concerns
How to Cite
References
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704.
Karaaslan E. Anesthetic management of rhinoorbitocerebral mucormycosis; Focus on challenges. J Mycol Med. 2019;29(3):219-22.
Eckmann DM, Seligman I, Coté CJ, Hussong JW. Mucormycosis supraglottitis on induction of anesthesia in an immunocompromised host. Anesth Analg. 1998;86(4):729-30.
Tomas ME, Kundrapu S, Thota P, Sunkesula VC, Cadnum JL, Mana TS, et al. Contamination of Health Care Personnel During Removal of Personal Protective Equipment. JAMA Intern Med. 2015;175(12):1904-10.
Okamoto K, Rhee Y, Schoeny M, Lolans K, Cheng J, Reddy S, et al. Impact of doffing errors on healthcare worker self-contamination when caring for patients on contact precautions. Infect Control Hosp Epidemiol. 2019;40(5):559-65.
Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology. 2020;132(6):1346-61.
Brown S, Patrao F, Verma S, Lean A, Flack S, Polaner D. Barrier System for Airway Management of COVID-19 Patients. Anesth Analg. 2020;131(1):e34-e5.
Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020;382(20):1957-8.
Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.
La Colla L, Albertin A, La Colla G, Mangano A. Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used. Br J Anaesth. 2007;99(3):353-8.
Barodka VM, Acheampong E, Powell G, Lobach L, Logan DA, Parveen Z, et al. Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. J Transl Med. 2006;4:46.
- Abstract Viewed: 141 times
- PDF Downloaded: 144 times